Bio Techne (Brazil) Performance
| T1CH34 Stock | 13.08 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.12, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bio Techne's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bio Techne is expected to be smaller as well. At this point, Bio Techne has a negative expected return of -0.0907%. Please make sure to confirm Bio Techne's treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to decide if Bio Techne performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bio Techne has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Bio Techne is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 199.1 M | |
| Total Cashflows From Investing Activities | -96.9 M |
Bio |
Bio Techne Relative Risk vs. Return Landscape
If you would invest 1,407 in Bio Techne on September 3, 2024 and sell it today you would lose (99.00) from holding Bio Techne or give up 7.04% of portfolio value over 90 days. Bio Techne is generating negative expected returns and assumes 2.3315% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than Bio, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bio Techne Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Techne's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bio Techne, and traders can use it to determine the average amount a Bio Techne's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0389
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | T1CH34 |
Estimated Market Risk
| 2.33 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bio Techne is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio Techne by adding Bio Techne to a well-diversified portfolio.
Bio Techne Fundamentals Growth
Bio Stock prices reflect investors' perceptions of the future prospects and financial health of Bio Techne, and Bio Techne fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Stock performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0771 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 73.29 B | |||
| Shares Outstanding | 4.72 B | |||
| Price To Book | 7.19 X | |||
| Price To Sales | 65.05 X | |||
| Revenue | 1.11 B | |||
| EBITDA | 413.76 M | |||
| Total Debt | 243.41 M | |||
| Book Value Per Share | 0.38 X | |||
| Cash Flow From Operations | 325.27 M | |||
| Earnings Per Share | 0.28 X | |||
| Total Asset | 2.29 B | |||
About Bio Techne Performance
By analyzing Bio Techne's fundamental ratios, stakeholders can gain valuable insights into Bio Techne's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bio Techne has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bio Techne has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Bio Techne performance evaluation
Checking the ongoing alerts about Bio Techne for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio Techne help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bio Techne generated a negative expected return over the last 90 days |
- Analyzing Bio Techne's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio Techne's stock is overvalued or undervalued compared to its peers.
- Examining Bio Techne's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bio Techne's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio Techne's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bio Techne's stock. These opinions can provide insight into Bio Techne's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |